Brief: Blue Water Announces Acquisition Of Entadfi®, An FDA-Approved Benign Prostatic Hyperplasia Asset

Onconetix

20/04/2023 12:34

April 20 (Reuters) - Blue Water Vaccines Inc  BWV.O :
    * BLUE WATER ANNOUNCES ACQUISITION OF ENTADFI®, AN
FDA-APPROVED
BENIGN PROSTATIC HYPERPLASIA ASSET

Source text for Eikon:  ID:nGNX3qwdN8 
Further company coverage:  BWV.O